Research Portal

All Wales Medicines Strategy Group Final Appraisal Report - Abacavir 600mg/lamivudine 300mg (Kivexa) in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus infection in adults and adolescents from 12 years of age.

Research output: Book/Report › Commissioned report

  • D. Hughes
  • D.A. Hughes
  • [No Value] All Wales Strategy Group.
Original languageEnglish
PublisherUnknown
Commissioning bodyNHS Wales
Edition2008
Publication statusPublished - 1 Jan 2008
View graph of relations